Effect of prescription of regulating qi to relieve pain combined with syndrome differentiation intervention in the treatment of epigastric pain syndrome due to liver qi invading the stomach
ZHOU Wei
Department of Traditional Chinese Medicine, Suzhou Yongding Hospital
Abstract:Objective To explore the clinical effect of prescription of regulating qi to relieve pain combined with syndrome differentiation intervention in the treatment of epigastric pain syndrome of liver qi invading the stomach. Methods A total of 93 patients with epigastric pain syndrome of liver qi invading stomach in clinic of Traditional Chinese Medicine, Suzhou Yongding Hospital from April 2019 to April 2021 were selected as the research objects. They were divided into the experimental group (49 cases) and the control group (44 cases) by random coin toss method. Patients in the control group were treated with Rabeprazole, while patients in the experimental group were treated with prescription of regulating qi to relieve pain combined with traditional Chinese medicine syndrome differentiation. The therapeutic effect and symptom score of the two groups were compared. Results The overall response rate (93.88%) of the experimental group was higher than that of the control group (79.55%), and the difference was statistically significant (P<0.05).After treatment, the scores of symptoms of belching, acid reflux, nausea and vomiting and loss of appetite in the experimental group were lower than those in the control group, the differences were statistically significant (P<0.05). Conclusion The overall effect of prescription of regulating qi to relieve pain combined with traditional Chinese medicine syndrome differentiation in the treatment of epigastric pain syndrome of liver qi invading the stomach is ideal, which is worthy of reference and promotion in clinical practice.
周巍. 中药理气止痛方配合辨证干预治疗胃脘痛肝气犯胃证的效果[J]. 中国当代医药, 2022, 29(6): 95-97转102.
ZHOU Wei. Effect of prescription of regulating qi to relieve pain combined with syndrome differentiation intervention in the treatment of epigastric pain syndrome due to liver qi invading the stomach. 中国当代医药, 2022, 29(6): 95-97转102.